Modern Healthcare News
 
RSS feed

Eli Lilly news and information

Vital Signs
'Bionic pancreas' helps Type 1 diabetics in initial study
By Sabriya Rice | June 17, 2014
A “bionic pancreas"—a device created by connecting a cellphone to a glucose monitor—showed great potential in helping people with Type 1 diabetes maintain control of their blood sugar, according to two randomized studies published June 15 in the New England Journal of Medicine.
FULL STORY »
 

Magazine
Dr. Cary Sennett named CEO of Asthma and Allergy Foundation, and other moves
By Modern Healthcare | June 14, 2014 | Print Magazine Print Magazine Subscription Details
Dr. Cary Sennett has been named president and CEO of the Asthma and Allergy Foundation of America.
FULL STORY »
 

Information
Pescovitz to take job at drugmaker Eli Lilly
By Jay Greene, Crain's Detroit Business | June 11, 2014
Dr. Ora Pescovitz, former CEO of the University of Michigan Health System in Ann Arbor, has accepted a job as a senior vice president at Eli Lilly & Co. in Indianapolis. She will start in October.
FULL STORY »
 

Information
New drugs may make a dent in lung, ovarian cancer
By Associated Press | May 31, 2014
New drugs are making a dent against some hard-to-treat cancers, but some results raise fresh questions about whether the benefit is worth the cost.
FULL STORY »
 

News
Eli Lilly revenue suffers after patent losses for Cymbalta, Evista
By Rachel Landen | April 24, 2014 | Basic Web Basic Web Subscription Details
Eli Lilly and Co. saw a sharp decline in its first-quarter earnings after recent U.S. patent expirations for two of its best-selling drugs cut sharply into the pharmaceutical company's revenue.
FULL STORY »
 


Advertisement | View Media Kit

News
NQF panel votes against sepsis central-line mandate
By Sabriya Rice | April 22, 2014 | Basic Web Basic Web Subscription Details
A National Quality Forum patient-safety committee on Tuesday overturned its previous endorsement of guidelines calling for central venous catheterization in some patients with severe sepsis and septic shock.
FULL STORY »
 

Information
Novartis, GSK, Lilly in multibillion-dollar deals
By Associated Press | April 22, 2014
Swiss pharmaceutical giant Novartis announced a series of multibillion-dollar deals Tuesday with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally.
FULL STORY »
 

Information
U.S. jury hits Takeda, Lilly with $9B penalty
By Associated Press | April 08, 2014
A U.S. jury ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly & Co., to pay $9 billion in punitive damages over a diabetes medicine linked to cancer. The drug companies said Tuesday they will "vigorously challenge" the decision.
FULL STORY »
 

Information
Two drugs show promise in slowing breast cancer
By Wall Street Journal | April 07, 2014
Two drugs from Pfizer and Eli Lilly & Co. that employ a new therapeutic approach showed promise in slowing the course of breast cancer, according to early-stage research released on Sunday.
FULL STORY »
 

News
NIH partners with pharmaceutical companies, not-for-profits to speed disease research
By Sabriya Rice | February 04, 2014 | Basic Web Basic Web Subscription Details
In what is being called an unprecedented partnership, the National Institutes of Health announced Tuesday that it is joining forces with 10 biopharmaceutical companies and several not-for-profit organizations to accelerate development of promising new diagnostics and treatments for Alzheimer's...
FULL STORY »
 

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.